Target Price | $58.81 |
Price | $58.67 |
Potential | 0.24% |
Number of Estimates | 21 |
21 Analysts have issued a price target Monster Beverage 2026 . The average Monster Beverage target price is $58.81. This is 0.24% higher than the current stock price. The highest price target is $71.00 21.02% , the lowest is $47.00 19.89% . | |
A rating was issued by 27 analysts: 13 Analysts recommend Monster Beverage to buy, 12 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Monster Beverage stock has an average upside potential 2026 of 0.24% . Most analysts recommend the Monster Beverage stock at Purchase. |
21 Analysts have issued a sales forecast Monster Beverage 2025 . The average Monster Beverage sales estimate is $8.0b . This is 6.76% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $8.3b 11.13% , the lowest is $7.7b 3.17% .
This results in the following potential growth metrics:
2024 | $7.5b | 4.94% |
---|---|---|
2025 | $8.0b | 6.76% |
2026 | $8.6b | 7.49% |
2027 | $9.3b | 7.98% |
2028 | $10.2b | 10.13% |
16 Analysts have issued an Monster Beverage EBITDA forecast 2025. The average Monster Beverage EBITDA estimate is $2.4b . This is 18.50% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.5b 24.77% , the lowest is $2.3b 13.00% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $2.0b | 1.36% |
---|---|---|
2025 | $2.4b | 18.50% |
2026 | $2.6b | 8.49% |
2027 | $2.8b | 9.92% |
2028 | $3.1b | 9.31% |
2024 | 26.84% | 6.01% |
---|---|---|
2025 | 29.79% | 11.01% |
2026 | 30.06% | 0.91% |
2027 | 30.60% | 1.80% |
2028 | 30.38% | 0.72% |
11 Monster Beverage Analysts have issued a net profit forecast 2025. The average Monster Beverage net profit estimate is $1.8b . This is 24.58% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.9b 29.05% , the lowest is $1.7b 20.27% .
This results in the following potential growth metrics and future Net Margins:
2024 | $1.4b | 3.25% |
---|---|---|
2025 | $1.8b | 23.74% |
2026 | $2.0b | 10.89% |
2027 | $2.2b | 9.53% |
2028 | $2.6b | 19.61% |
2024 | 19.35% | 7.80% |
---|---|---|
2025 | 22.43% | 15.91% |
2026 | 23.14% | 3.17% |
2027 | 23.47% | 1.43% |
2028 | 25.49% | 8.61% |
11 Analysts have issued a Monster Beverage forecast for earnings per share. The average Monster Beverage EPS is $1.84 . This is 24.32% higher than earnings per share in the financial year 2024. The highest EPS forecast is $1.91 29.05% , the lowest is $1.78 20.27% .
This results in the following potential growth metrics and future valuations:
2024 | $1.49 | 3.25% |
---|---|---|
2025 | $1.84 | 23.49% |
2026 | $2.04 | 10.87% |
2027 | $2.24 | 9.80% |
2028 | $2.68 | 19.64% |
Current | 39.54 | 14.68% |
---|---|---|
2025 | 31.82 | 19.52% |
2026 | 28.69 | 9.84% |
2027 | 26.20 | 8.68% |
2028 | 21.90 | 16.41% |
Based on analysts' sales estimates for 2025, the Monster Beverage stock is valued at an EV/Sales of 7.00 and an P/S ratio of 7.14 .
This results in the following potential growth metrics and future valuations:
Current | 7.47 | 2.33% |
---|---|---|
2025 | 7.00 | 6.29% |
2026 | 6.51 | 6.96% |
2027 | 6.03 | 7.39% |
2028 | 5.48 | 9.20% |
Current | 7.62 | 1.61% |
---|---|---|
2025 | 7.14 | 6.34% |
2026 | 6.64 | 6.96% |
2027 | 6.15 | 7.39% |
2028 | 5.58 | 9.20% |
Monster Beverage...
Analyst | Rating | Action | Date |
---|---|---|---|
Truist Securities |
Sell
➜
Sell
|
Unchanged | Apr 24 2025 |
UBS |
Neutral
➜
Neutral
|
Unchanged | Apr 17 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Apr 14 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Apr 02 2025 |
Needham |
Hold
➜
Hold
|
Unchanged | Feb 28 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Feb 28 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Feb 28 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Truist Securities:
Sell
➜
Sell
|
Apr 24 2025 |
Unchanged
UBS:
Neutral
➜
Neutral
|
Apr 17 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Apr 14 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Apr 02 2025 |
Unchanged
Needham:
Hold
➜
Hold
|
Feb 28 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Feb 28 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Feb 28 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.